Cannbiorx Life Sciences Stock Analysis
ATNFW Stock | USD 0.01 0.0001 1.19% |
CannBioRx Life Sciences is fairly valued with Real Value of 0.008064 and Hype Value of 0.01. The main objective of CannBioRx Life stock analysis is to determine its intrinsic value, which is an estimate of what CannBioRx Life Sciences is worth, separate from its market price. There are two main types of CannBioRx Life's stock analysis: fundamental analysis and technical analysis.
The CannBioRx Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. CannBioRx Life is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. CannBioRx Stock trading window is adjusted to America/New York timezone.
CannBioRx |
CannBioRx Stock Analysis Notes
The company had not issued any dividends in recent years. CannBioRx Life Sciences Corp. discovers and develops pharmaceutical drugs. 180 Life is traded on NASDAQ Exchange in the United States. For more info on CannBioRx Life Sciences please contact James Woody at 650 507 0669 or go to https://180lifesciences.com.CannBioRx Life Sciences Investment Alerts
CannBioRx Life is way too risky over 90 days horizon | |
CannBioRx Life has some characteristics of a very speculative penny stock | |
CannBioRx Life appears to be risky and price may revert if volatility continues | |
Net Loss for the year was (19.94 M) with profit before overhead, payroll, taxes, and interest of 0. | |
CannBioRx Life generates negative cash flow from operations | |
CannBioRx Life has a poor financial position based on the latest SEC disclosures | |
Latest headline from news.google.com: Acquisition by Mcgovern Jr. Donald A. of 15000 shares of CannBioRx Life at 0.67 subject to Rule 16b-3 |
CannBioRx Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 250.78 M.CannBioRx Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (4.93) | (5.18) | |
Return On Capital Employed | (78.73) | (74.80) | |
Return On Assets | (3.41) | (3.58) | |
Return On Equity | 140.46 | 147.48 |
Management Efficiency
CannBioRx Life Sciences has return on total asset (ROA) of (0.5162) % which means that it has lost $0.5162 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.7419) %, meaning that it generated substantial loss on money invested by shareholders. CannBioRx Life's management efficiency ratios could be used to measure how well CannBioRx Life manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 147.48 in 2025, whereas Return On Tangible Assets are likely to drop (5.18) in 2025. CannBioRx Life reported Non Currrent Assets Other of (15.66 Million) in 2024. Intangibles To Total Assets is likely to climb to 0.70 in 2025, whereas Total Current Assets are likely to drop slightly above 4 M in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.39) | (0.37) | |
Tangible Book Value Per Share | (5.30) | (5.04) | |
Enterprise Value Over EBITDA | (0.03) | (0.03) | |
Price Book Value Ratio | (13.85) | (13.16) | |
Enterprise Value Multiple | (0.03) | (0.03) | |
Price Fair Value | (13.85) | (13.16) | |
Enterprise Value | 709.6 K | 674.1 K |
The strategic decisions made by CannBioRx Life management significantly impact its financial stability and market performance. Evaluating these factors helps determine whether the stock is a worthwhile investment.
Technical Drivers
As of the 27th of March, CannBioRx Life shows the Downside Deviation of 10.31, mean deviation of 8.01, and Risk Adjusted Performance of 0.0666. CannBioRx Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CannBioRx Life Sciences downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if CannBioRx Life Sciences is priced correctly, providing market reflects its regular price of 0.0082999999 per share. As CannBioRx Life Sciences appears to be a penny stock we also recommend to validate its total risk alpha numbers.CannBioRx Life Sciences Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CannBioRx Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CannBioRx Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
CannBioRx Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CannBioRx Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on CannBioRx Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CannBioRx Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Marrone Pamela G over a month ago Acquisition by Marrone Pamela G of 32037 shares of CannBioRx Life subject to Rule 16b-3 | ||
Feldmann Marc over six months ago Acquisition by Feldmann Marc of 135377 shares of CannBioRx Life subject to Rule 16b-3 | ||
Mcgovern Jr. Donald A. over a year ago Acquisition by Mcgovern Jr. Donald A. of 15000 shares of CannBioRx Life at 0.67 subject to Rule 16b-3 |
CannBioRx Life Predictive Daily Indicators
CannBioRx Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CannBioRx Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 2232.77 | |||
Daily Balance Of Power | (0.10) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 0.0078 | |||
Day Typical Price | 0.008 | |||
Price Action Indicator | 5.0E-4 | |||
Period Momentum Indicator | (0.0001) | |||
Relative Strength Index | 44.84 |
CannBioRx Life Forecast Models
CannBioRx Life's time-series forecasting models are one of many CannBioRx Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CannBioRx Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CannBioRx Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how CannBioRx Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CannBioRx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CannBioRx Life. By using and applying CannBioRx Stock analysis, traders can create a robust methodology for identifying CannBioRx entry and exit points for their positions.
Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding CannBioRx Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
All Next | Launch Module |
Additional Tools for CannBioRx Stock Analysis
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.